GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
GM1 Ganglioside Modifies α-Synuclein Toxicity and is Neuroprotective in a Rat α-Synuclein Model of Parkinson’s Disease
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-06-10
DOI
10.1038/s41598-019-42847-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sex-Related Abnormalities in Substantia Nigra Lipids in Parkinson’s Disease
- (2018) T. N. Seyfried et al. ASN Neuro
- Disease Modification in Parkinson's Disease: Current Approaches, Challenges, and Future Considerations
- (2018) Anthony E. Lang et al. MOVEMENT DISORDERS
- Suppression of autophagy in the brain of transgenic mice with overexpression of А53Т-mutant α-synuclein as an early event at synucleinopathy progression
- (2018) Alexander B. Pupyshev et al. NEUROSCIENCE LETTERS
- Altered expression of genes involved in ganglioside biosynthesis in substantia nigra neurons in Parkinson’s disease
- (2018) Jay S. Schneider PLoS One
- Enhanced Autophagy Contributes to Protective Effects of GM1 Ganglioside Against Aβ1-42-Induced Neurotoxicity and Cognitive Deficits
- (2017) Ruwei Dai et al. NEUROCHEMICAL RESEARCH
- AAV1/2-induced overexpression of A53T-α-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson’s disease
- (2017) Chi Wang Ip et al. Acta Neuropathologica Communications
- Mechanisms underlying extensive Ser129-phosphorylation in α-synuclein aggregates
- (2017) Shigeki Arawaka et al. Acta Neuropathologica Communications
- GDNF signaling implemented by GM1 ganglioside; failure in Parkinson's disease and GM1-deficient murine model
- (2015) Piotr Hadaczek et al. EXPERIMENTAL NEUROLOGY
- GM1 ganglioside in Parkinson's disease: Pilot study of effects on dopamine transporter binding
- (2015) Jay S. Schneider et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- Gangliosides: glycosphingolipids essential for normal neural development and function
- (2015) Cara-Lynne Schengrund TRENDS IN BIOCHEMICAL SCIENCES
- N-Alpha-Acetylation of α-Synuclein Increases Its Helical Folding Propensity, GM1 Binding Specificity and Resistance to Aggregation
- (2014) Tim Bartels et al. PLoS One
- TFEB-mediated autophagy rescues midbrain dopamine neurons from -synuclein toxicity
- (2013) M. Decressac et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Deficiency of ganglioside GM1 correlates with Parkinson's disease in mice and humans
- (2012) Gusheng Wu et al. JOURNAL OF NEUROSCIENCE RESEARCH
- A randomized, controlled, delayed start trial of GM1 ganglioside in treated Parkinson's disease patients
- (2012) Jay S. Schneider et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- GDNF fails to exert neuroprotection in a rat -synuclein model of Parkinson's disease
- (2011) M. Decressac et al. BRAIN
- Progressive Neurodegeneration or Endogenous Compensation in an Animal Model of Parkinson's Disease Produced by Decreasing Doses of Alpha-Synuclein
- (2011) James B. Koprich et al. PLoS One
- Lipid rafts: Keys to neurodegeneration
- (2010) Cara-Lynne Schengrund BRAIN RESEARCH BULLETIN
- Expression of human A53T alpha-synuclein in the rat substantia nigra using a novel AAV1/2 vector produces a rapidly evolving pathology with protein aggregation, dystrophic neurite architecture and nigrostriatal degeneration with potential to model the pathology of Parkinson's disease
- (2010) James B Koprich et al. Molecular Neurodegeneration
- Protective Role of Endogenous Gangliosides for Lysosomal Pathology in a Cellular Model of Synucleinopathies
- (2009) Jianshe Wei et al. AMERICAN JOURNAL OF PATHOLOGY
- Targets for neuroprotection in Parkinson's disease
- (2008) Talene A. Yacoubian et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started